MC2217A1 - Procede de preparation d'une composition pharmaceutique a usage optalmologique contenant de l'hexetidine ou ses derives ou sels - Google Patents

Procede de preparation d'une composition pharmaceutique a usage optalmologique contenant de l'hexetidine ou ses derives ou sels

Info

Publication number
MC2217A1
MC2217A1 MC912178A MC2178A MC2217A1 MC 2217 A1 MC2217 A1 MC 2217A1 MC 912178 A MC912178 A MC 912178A MC 2178 A MC2178 A MC 2178A MC 2217 A1 MC2217 A1 MC 2217A1
Authority
MC
Monaco
Prior art keywords
salts
preparation
pharmaceutical composition
derivatives
optalmological
Prior art date
Application number
MC912178A
Other languages
English (en)
French (fr)
Inventor
Salkin Andre
Original Assignee
Salkin Andre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salkin Andre filed Critical Salkin Andre
Publication of MC2217A1 publication Critical patent/MC2217A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
MC912178A 1990-04-18 1991-03-22 Procede de preparation d'une composition pharmaceutique a usage optalmologique contenant de l'hexetidine ou ses derives ou sels MC2217A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR909004945A FR2661091B1 (fr) 1990-04-18 1990-04-18 Utilisation de l'hexetidine ou de ses derives ou sels pour la preparation d'une composition pharmaceutique a usage ophtalmologique.

Publications (1)

Publication Number Publication Date
MC2217A1 true MC2217A1 (fr) 1993-02-02

Family

ID=9395848

Family Applications (1)

Application Number Title Priority Date Filing Date
MC912178A MC2217A1 (fr) 1990-04-18 1991-03-22 Procede de preparation d'une composition pharmaceutique a usage optalmologique contenant de l'hexetidine ou ses derives ou sels

Country Status (12)

Country Link
EP (1) EP0453337B1 (pt)
JP (1) JPH04234818A (pt)
AT (1) ATE158719T1 (pt)
AU (1) AU643772B2 (pt)
BR (1) BR9101544A (pt)
CA (1) CA2039566A1 (pt)
DE (1) DE69127767T2 (pt)
DK (1) DK0453337T3 (pt)
ES (1) ES2109937T3 (pt)
FR (1) FR2661091B1 (pt)
HU (1) HUT57985A (pt)
MC (1) MC2217A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2074484A1 (en) * 1990-11-26 1992-05-27 Edward J. Carlin Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same
DE10147186A1 (de) * 2001-09-25 2003-04-24 Beiersdorf Ag Wirkstoffkombinationen aus Polyhexamethylenbiguanid-Hydrochlorid und Distearyldimethylammoniumchlorid und Zubereitungen, solche Wirkstoffkombinationen enthaltend
US9737609B2 (en) * 2014-08-20 2017-08-22 Professional Compounding Centers Of America (Pcca) Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL89993C (pt) * 1954-08-02
FR2552305B1 (fr) * 1983-09-22 1985-12-20 Salkin Andre Composition a pouvoir bactericide eleve contenant un biguanide et une pyrimidine
EP0215136B1 (de) * 1985-09-02 1988-06-22 Artesan Pharma Gesellschaft mit beschränkter Haftung Hexetidin 1,3-Bis-(2-ethylhexyl)-hexahydro-5-methyl-5-pyrimidinamin enthaltendes therapeutisch wirkendes Mittel, sowie Verfahren zum Herstellen desselben und Verwendung als vaginales Desinfektionsmittel
US4666517A (en) * 1986-06-04 1987-05-19 Colgate-Palmolive Co. Antiplaque oral composition

Also Published As

Publication number Publication date
ES2109937T3 (es) 1998-02-01
EP0453337A2 (fr) 1991-10-23
EP0453337B1 (fr) 1997-10-01
DE69127767D1 (de) 1997-11-06
HUT57985A (en) 1992-01-28
BR9101544A (pt) 1991-12-10
FR2661091A1 (fr) 1991-10-25
JPH04234818A (ja) 1992-08-24
AU643772B2 (en) 1993-11-25
DE69127767T2 (de) 1998-04-30
AU7513291A (en) 1991-10-24
EP0453337A3 (en) 1992-11-25
HU911272D0 (en) 1991-10-28
ATE158719T1 (de) 1997-10-15
FR2661091B1 (fr) 1994-10-21
CA2039566A1 (en) 1991-10-19
DK0453337T3 (da) 1998-05-18

Similar Documents

Publication Publication Date Title
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE59508961D1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
DE68904462T2 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
DK0594770T3 (da) Oftalmologiske blandinger
DE69516110T2 (de) Verwendung von riluzol zur behandlung mitochondrialer erkrankungen
MC2217A1 (fr) Procede de preparation d'une composition pharmaceutique a usage optalmologique contenant de l'hexetidine ou ses derives ou sels
DE69013431D1 (de) Anthocyanidine zur Behandlung von Augenkrankheiten.
ATE86112T1 (de) Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute.
NO179472C (no) Opplösning omfattende benzoxoniumklorid for behandling av kontaktlinser, og anvendelse derav til konservering av kontaktlinser og legemidler for öynene
FR2656527B1 (fr) Solution d'irrigation oculaire utilisee en therapeutique pour la protection endotheliale et la conservation de la cornee.
KR890001555A (ko) 요산 배설용 조성물
ATE78160T1 (de) Verwendung von ''naftidrofuryl'' zur behandlung von neuropathien.
RU93015155A (ru) Лекарственное средство для лечения дистрофических заболеваний и травм глазных тканей
PT97878A (pt) Processo para a preparacao de uma composicao farmaceutica para uso oftalmico contendo hexetidina ou seus derivados ou sais
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
KR890000089A (ko) 신장 질환 치료제
IT8919215A0 (it) Dispositivo per la cura chirurgica dell'ametropia.

Legal Events

Date Code Title Description
YP Annual fee paid